Please assess the completion status of the following clinical trial:

Trial Title: Oral Triiodothyronine for Infants Less Than 5 Months & Malnourished Children Undergoing Cardiopulmonary Bypass in Indonesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children undergoing cardiopulmonary bypass~* Age 3 years old or less~* Aristotle score 6 and above~* Total correction or biventricular repair~Exclusion Criteria:~* Single ventricle defects~* Body weight less than 2 kg at the time of recruitment~* Presentation with sepsis~* Tachyarrhythmia or any other arrhythmia before surgery~* Creatinine level of more than 2 mg/dL~* Known thyroid disease~* Known lung abnormalities (incl. infection) before surgery.

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 36 Months
- Healthy Volunteers: f

Study Arms:
- Tetronine (Type: EXPERIMENTAL): Oral T3 (Tetronine) is given 1 mcg/kg every 6 hourly through naso-gastric tube since induction of anesthesia for 60 hours
- Placebo (Type: PLACEBO_COMPARATOR): Placebo (saccharin lactic) is given every 6 hourly through naso-gastric tube since induction of anesthesia for 60 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).